Abstract
The federal pharmacist provider status bill introduced in the U.S. House of Representatives (H.R. 4190) on March 11, 2014, defers to states' scope of practice for what services a pharmacist can provide and be compensated for. This legislation has placed even greater attention on understanding the state-to-state variability in what pharmacists' scope of practice entails. With this in mind, the National Alliance of State Pharmacy Associations (NASPA) has expanded upon previous research from early 2013 to further examine the variability between state collaborative practice agreement provisions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
